Serve Robotics Eyes Robot Expansion, Lyra Surges on Trial Success, Moderna Gets FDA Nod
Stay ahead of the stock market with a roundup of market-moving news, everyday.
️BTC/USD: $104,365.40 (-1.26%)
S&P 500: $5,907.27 (-0.075%)
️U.S. 10-Year Treasury: 4.45% (+0.032)
VIX: $18.94 (+1.99%)
*Price data accurate as of 12:21 pm EST.
Bull Whisper: Get Trade Ideas & Market Insights Every Day, Premarket
Wall Street makes money nearly every day.
Why shouldn’t you? Sign up for HighStrike’s daily newsletter, Bull Whisper!
The one daily newsletter that gets you up to speed fast. Market news, a watchlist, and real analysis — all in one quick read.
No noise. No fluff. Just actionable insights from a team with over 25 years of combined trading experience.
The Daily Update: Small-cap AI stocks offer higher growth potential than major tech giants; Serve Robotics shows 37% upside as it plans robot deployment expansion; AppLovin reported 40% revenue growth and 144% net income increase; Lyra Therapeutics surged 443% on successful Phase 3 trial results; Campbell's exceeded Q3 expectations with 4% sales growth; SAIC posted mixed results with revenue growth but missed earnings targets; Moderna gained 5% on FDA approval for lower-dose COVID vaccine despite ongoing funding challenges.
This newsletter is powered by TradeZero.
With the SEC enforcing strict regulations on these securities, day traders need reliable solutions that comply with regulations without eroding their profit margins. Single Use Locates offer a streamlined, one-time solution for trading these high-regulation securities, offering a more budget-friendly alternative to Pre-Borrows (PB) while adhering to SEC guidelines.
TradeZero’s Single Use Locates provide a valuable solution for day traders seeking affordable, compliant, and flexible short-selling options.
Watch these 2 Small-Cap AI Stocks for Exponential Growth
As AI unleashes new revenue streams, stock traders should integrate them in their investment strategies.
Why Did Lyra Therapeutics’ Stock Rocket Past 440% in Premarket Today
Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.
Why is Moderna’s Stock Gaining in Premarket Trading Today?
Moderna stock jumped in premarket trading after the FDA granted limited approval for mNEXSPIKE, a new COVID-19 vaccine.
Campbell’s Company (CPB) Reports Better-than-Expected Results for Q3 FY’25
Campbell's Company exceeded expectations in Q3 fiscal 2025 with a 4% increase in net sales to $2.5 billion.
SAIC Reports Mixed Results for First Quarter of Fiscal Year 2026
SAIC's first-quarter revenues grew by 2% to $1.88 billion, surpassing expectations. However, its earnings per share fell short at $1.42, below expectations.
This newsletter was brought to you by HighStrike!
The following are some levels that HighStrike traders are currently watching. Continue reading to learn why these stocks are in focus and where they’re heading. You can join the HighStrike community to improve your trading skills and connect to 10,000+ traders.
Check out our Discord to see the full game plan for today.
ES levels to watch today:
Above:
5,959, 5,981, and 5,902 snow line
6,016 tree line
5,924 Fire line
Below:
5,888 snow line
5,867 tree line
NQ levels to watch today:
Above:
21,744 and 21,943 sky line
22,264 tree line
21,424 snow line
Below:
20,900 snow line
21,224 and 21,103 sky line
Check out the pre-market video for a detailed explanation of this trade and targets!
HighStrike is the fastest-growing community of retail traders on the planet. The community’s 10,000+ traders from 142 countries gather on Discord daily, where HighStrike’s funded traders share live trade walkthroughs on video, answer questions from the community, vet trade ideas from members, and share their unique insights on the markets. It’s the new home for day traders.
Tweet of the Day:
Disclaimer: The Tokenist does not provide financial advice. Please consult our website policy prior to making financial decisions.